Your browser doesn't support javascript.
loading
Pharmacokinetic-pharmacodynamic modeling of the antitumor effect of TM208 and EGFR-TKI resistance in human breast cancer xenograft mice.
Ji, Xi-Wei; Ji, Shuang-Min; Li, Run-Tao; Wu, Ke-Hua; Zhu, Xiao; Lu, Wei; Zhou, Tian-Yan.
Afiliação
  • Ji XW; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100191, China.
  • Ji SM; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Li RT; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Wu KH; State Key Laboratory of Natural and Biomimetic Drugs, Beijing 100191, China.
  • Zhu X; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Lu W; School of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
  • Zhou TY; Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Acta Pharmacol Sin ; 37(6): 825-33, 2016 Jun.
Article em En | MEDLINE | ID: mdl-27133303

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Mama / Neoplasias da Mama / Receptores ErbB / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Acta Pharmacol Sin Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Mama / Neoplasias da Mama / Receptores ErbB / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Acta Pharmacol Sin Ano de publicação: 2016 Tipo de documento: Article